Regulus Therapeutics Banner Image

Regulus Therapeutics

  • Ticker RGLS
    Exchange NASDAQ More
  • Industry Biotechnology More
  • Sector Healthcare More
Regulus Therapeutics Logo Image
  • 51-200 Employees
  • Based in San Diego, California
Regulus Therapeutics Inc. (NASDAQ:RGLS) is a biopharmaceutical company leading the discovery and development of innovative medicines targeting microRNAs. Regulus has leveraged its oligonucleotide drug discovery and development expertise to develop a well-balanced microRNA therapeutics pipeline complemented by a maturing microMarkersSM biomarkers platform and a rich intellectual propertyMore estate to retain its leadership in the microRNA field.
4.8 / 5.0 (214)

Regulus Therapeutics reports have an aggregate usefulness score of 4.8 based on 214 reviews.

Regulus Therapeutics

Most Recent Annual Report

Regulus Therapeutics
MOST RECENT 2022 Annual Report and Form 10K

Regulus Therapeutics does not currently have any hardcopy reports on AnnualReports.com. Click the button below to request a report when hardcopies become available.

Request Information

Older/Archived Annual Reports

Regulus Therapeutics Logo Image

Rate This Report

Your vote helps our reports be more useful
Rating Saved!

Thank you for your feedback!